江苏北人(688218) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months was CNY 262,436,604.82, down 14.76% year-on-year [7]. - Net profit attributable to shareholders of the listed company was CNY 13,617,612.10, a decline of 57.77% compared to the same period last year [7]. - Basic earnings per share were CNY 0.12, a decrease of 67.57% compared to CNY 0.37 in the previous year [7]. - Operating profit fell by 81.17% to ¥6,599,245.97 from ¥35,050,257.03, mainly due to revenue decline and increased project costs caused by the pandemic [17]. - Net profit decreased by 65.38% to ¥11,106,788.76 from ¥32,085,807.26, attributed to the same factors affecting operating profit [17]. - The company reported a significant increase in prepayments from ¥5,980,659.91 to ¥22,096,170.47, an increase of approximately 269.5% [26]. - The company reported a total profit of ¥1,521,285.17 for Q3 2020, down from ¥3,376,082.04 in Q3 2019, a decline of 55.0% [31]. Cash Flow - The net cash flow from operating activities for the first nine months was CNY 25,594,189.99, a significant recovery from a loss of CNY 62,889,880.50 in the previous year [6]. - Cash flow from operating activities was ¥25,594,189.99, a significant recovery from -¥62,889,880.50 in the previous year, driven by increased collection efforts [17]. - The cash flow from operating activities for the first nine months of 2020 was ¥25.59 million, a turnaround from a negative cash flow of ¥62.89 million in the same period of 2019 [37]. - The company reported cash inflow from investment activities of approximately ¥1.04 billion in the first nine months of 2020, compared to ¥313.52 million in the same period of 2019, showing a substantial increase [38]. - The net cash flow from financing activities was negative at ¥36.79 million in Q3 2020, contrasting with a positive cash flow of ¥2.89 million in Q3 2019 [38]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,202,951,265.36, a decrease of 3.32% compared to the end of the previous year [6]. - Total liabilities decreased from ¥407,137,013.96 to ¥371,174,633.02, a decline of around 8.8% [24]. - Total equity decreased from ¥837,097,443.58 to ¥831,776,632.34, a slight decrease of about 0.6% [24]. - Cash and cash equivalents decreased by 67.73% to ¥12,435,539.81 from ¥38,534,983.02 due to idle fundraising cash management [15]. - Accounts receivable increased by 49.13% to ¥58,961,028.23 from ¥39,535,505.11 as clients adopted more note settlements [15]. - Total liabilities decreased significantly, with long-term borrowings dropping to zero from ¥19,462,933.00 due to repayment [15]. Research and Development - The company's R&D expenditure accounted for 5.64% of operating revenue, an increase of 0.82 percentage points compared to the previous year [7]. - Research and development expenses for Q3 2020 were ¥4,936,206.31, slightly down from ¥5,629,431.67 in Q3 2019, a decrease of 12.3% [29]. - Research and development expenses amounted to ¥4.16 million in Q3 2020, a decrease of about 26.1% from ¥5.63 million in Q3 2019 [34]. Shareholder Information - The total number of shareholders at the end of the reporting period was 6,742, with the largest shareholder holding 22.82% of the shares [12]. - The company’s equity capital remained unchanged at RMB 117,340,000.00, indicating stability in shareholder equity [44]. Tax and Subsidies - Government subsidies recognized in the first nine months amounted to CNY 6,082,379.25, contributing positively to the financial results [9]. - The company reported a 90.98% decrease in income tax expenses to ¥363,983.98 from ¥4,034,842.76, reflecting lower total profit [17].